Ví dụ về việc sử dụng Clostridium difficile infection trong Tiếng anh và bản dịch của chúng sang Tiếng việt
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
What is clostridium difficile infections?
The maintenance of normal physiological conditions in thecolon may reduce the probability of recurrence of Clostridium difficile infection.[5][6].
What is a Clostridium Difficile Infection?
This technique has shown promise in treating other types of gastrointestinal disorders,such as recurrent Clostridium difficile infection and inflammatory bowel disease(IBD).
Clostridium Difficile infection: update on diagnosis, epidemiology, and treatment strategies.
What is C. Diff or Clostridium Difficile Infection?
Clostridium difficile infection can occur, especially after a course of antibiotics.
From combined analysis of all patient reports of FMT for recurrent Clostridium difficile infection in the literature, the effectiveness for cure is over 90%.
Clostridium difficile infection may occur, especially after taking a course of antibiotics.
And this has turned out to be very effective infighting certain intransigent infectious diseases like Clostridium difficile infections that can stay with people for years and years and years.
Clostridium difficile infection can take place, particularly after a course of antibiotics.
Tigecycline is recommended by the European Society of Clinical Microbiology and Infection as apotential salvage therapy for complicated and severe refractory Clostridium difficile infection.
There are around 12,000 cases of Clostridium difficile infection(CDI) each year in the UK and during 1999 to 2007, deaths from CDI peaked at around 4,000 per year.
Celiac disease Crohn's disease Ulcerative colitis[18] Chronic pancreatitis Cystic fibrosis Intestinal infection, e.g. Clostridium difficile infection.[19] Malabsorption Short bowel syndrome.
Colestyramine can be helpful in the treatment of Clostridium difficile infections, to absorb toxins A and B, and reduce the diarrhea and the other symptoms these toxins cause.
According to the authors of the new study, long-term PPI use has been implicated in a range of conditions,including"bone fracture, Clostridium difficile infection, pneumonia, myocardial infarction, and even stroke.".
Animal studies have not shown any induction of Clostridium difficile infection.[7] As with any other penicillin, convulsions can occur if very high doses are given.
The study also met its exploratory endpoint of global cure(77.7% for fidaxomicin vs. 67.1% for vancomycin).[11] Clinical cure was defined as patientsrequiring no further therapy for the treatment of'Clostridium difficile infection two days after completion of study medication.
Clostridium difficile infection(CDI) accounts for 20%-30% of cases of antibiotic-associated diarrhea and is the most commonly recognized cause of infectious diarrhea in healthcare settings.
It should not be used for people with diarrhea caused by an infection, for example with Clostridium difficile infection, since the slowing of peristalsis can prevent clearing of the infectious organism.[1].
Clostridium difficile infection(CDI) is one of the most common hospital-acquired infections, and is a frequent cause of morbidity and mortality among elderly hospitalized patients.
Fecal microbiota transplantation(FMT)has been shown to be effective in treating relapsing or refractory Clostridium difficile infection, but practical barriers and safety concerns have prevented its widespread use.
Clostridium difficile infection(CDI) can affect adults and children alike, and it can be very recurrent even after treatment with standard antibiotics- and needless to say it can cause great illness and death.
In one small but dramatic example of what might one day be routine,Finnish researchers reported in March that patients with recurring Clostridium difficile infections recovered after fresh fecal material from healthy donors was transplanted into their guts.
It is used for the treatment of Clostridium difficile infection, which is also known as Clostridium difficile associated diarrhea, and can develop into Clostridium difficile colitis and pseudomembranous colitis.
Common side effects include constipation, feeling weak, and throat inflammation.[5] Serious side effects may include osteoporosis,low blood magnesium, Clostridium difficile infection, and pneumonia.[5] Use in pregnancy and breastfeeding is of unclear safety.[8] It works by blocking H+/K+-ATPase in the parietal cells of the stomach.
In line with an intent to take a leadership position in the developing microbiome therapy field, Nestlé Health Science has signed an exclusive agreement outside the United States and Canada for Seres Therapeutics' novel class of microbiome therapeutics(Ecobiotics®)in the fields of Clostridium difficile infections(CDI, such as SER-109 and SER 262) and Inflammatory Bowel Disease(IBD; such as SER-287 and SER-301).
Common side effects include headache, constipation, dry mouth, and abdominal pain.[3]Serious side effects may include angioedema, Clostridium difficile infection, and pneumonia.[3] Use in pregnancy appear to be safe while safety during breastfeeding is unclear.[6] Esomeprazole is the S isomer of omeprazole.[3] It works by blocking H+/K+-ATPase in the parietal cells of the stomach.
Common side effects include diarrhea, abdominal pain, and nausea.[2]Serious side effects may include osteoporosis, low blood magnesium, Clostridium difficile infection, anaphylaxis, and pneumonia.[2] Use in pregnancy and breastfeeding is of unclear safety.[4] It works by blocking H+/K+-ATPase in the parietal cells of the stomach.[2].
Chlamydia infection Clostridium difficile associated diarrhea Trachoma Tuberculosis Leprosy Buruli ulcer[9].